シグナル伝達阻害剤の探索, 合成および生物活性
スポンサーリンク
概要
- 論文の詳細を見る
Oncogene product functions are mainly distUrbance of cellular signal transduction and modification of specific gene expression. Several oncogenes are known to be related to human neoplastic diseases. If these onocogenes play important roles in the progression of cancer, it should be possible to develop new antitumor drugs inhibiting oncogene product activities. We have isolated various signal transduction inhibitors such as tyrosine kinase inhibitors, Ras function inhibitors, and phosphatidylinositol turnover inhibitors from microorganisms and plants. In the present review, we describe isolation, synthesis and biological activities of tyrosine phosphatase and Ras function inhibitors which were recently isolated.<BR>Intracellular tyrosine phosphorylation should be regulated by both tyrosine kinases and tyrosine phosphatases. Therefore, we screened microbial culture filtrates for tyrosine phosphatase inhibitors and isolated a novel nitrosamine dephostatin from Streptomyces. We also established a practical synthetic route for dephostatin. Since dephostatin is not stable enough, we synthesized several structurally related dephostatin analogs. Among them a regioisomer of dephostatin showed tyrosine phosphatase inhibitory activity equivalent to that of dephostatin, and also had increased stability.<BR>We isolated conophylline and the novel aglaiastatin from tropical plant extracts as Ras function inhibitors. Conophyline and aglaiastatin induced normal phenotypes in K-ras-expressing cells. Since farnesl protein transferase (FPTase) is necessary for the Ras activity, we also screened microbial culture filtrates for FPTase inhibitors. As a result, we isolated 4 novel compounds, valinoctin A and B, and saquayamaycin E and F. The absolute configuration of valinoctin A was determined by a synthetic method together with crystallographic analysis.
- 社団法人 有機合成化学協会の論文
著者
関連論文
- 新規NF-KB阻害剤Dehydroxymethylepoxyquinomicin (DHMEQ)による抗癌剤感受性獲得への試み
- HP-090-6 胃癌腹膜播種モデルにおける新規NFκB阻害剤の腹膜への細胞接着抑制効果の検討(胃(分子標的・免疫療法),ハイブリッドポスター,第109回日本外科学会定期学術集会)
- SF-049-2 新規NF-κB阻害剤DHMEQの各種免疫担当細胞に対する効果(第108回日本外科学会定期学術集会)
- 81(P-10) α-マンゴスチンとその関連物質の合成と生物活性(ポスター発表の部)
- 71 制癌性抗生物質ブレオマイシン各部位の合成とDNA切断分子の設計(口頭発表の部)
- APP-059 前立腺癌による悪液質に対するNF-κB阻害剤の有用性の基礎的検討(総会賞応募(ポスター))
- DP-169-1 NF-kBおよびNFAT活性阻害とdonor specific transfuionによる免疫抑制効果(第108回日本外科学会定期学術集会)
- アポト-シスと抗癌剤 (10月第5土曜特集 アポト-シス) -- (ストレスとアポト-シス)
- 癌遺伝子機能調節物質 (細胞機能研究のための低分子プロ-ブ) -- (細胞機能調節物質)
- rasがん遺伝子の作用を阻害する物質 (1995年の化学-6-)
- 微生物由来がん遺伝子作用阻害剤の生物活性
- シグナル伝達阻害剤の探索, 合成および生物活性
- 癌遺伝子作用を抑制する微生物二次代謝産物
- シグナル伝達阻害剤の探索, 合成および生物活性